Tobacco smoke is a source of toxic reactive glycation products
Smokers have a significantly higher risk for developing coronary and cerebrovascular
disease than nonsmokers. Advanced glycation end products (AGEs) are reactive, cross …
disease than nonsmokers. Advanced glycation end products (AGEs) are reactive, cross …
Advanced glycation endproducts and cigarette smoking.
ID Nicholl, R Bucala - Cellular and molecular biology (Noisy-le …, 1998 - europepmc.org
The incidence of certain ageing sequelae such as lung and cardiovascular disease and
cataract are higher in smokers than in non-smokers. We recently proposed that certain …
cataract are higher in smokers than in non-smokers. We recently proposed that certain …
[HTML][HTML] Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers
Abstract Background Advanced glycation endproducts (AGEs) arise from the spontaneous
reaction of reducing sugars with the amino groups of macromolecules. AGEs accumulate in …
reaction of reducing sugars with the amino groups of macromolecules. AGEs accumulate in …
Role of hyperglycemia-induced advanced glycation end product (AGE) accumulation in atherosclerosis
S Yamagishi, T Matsui - Annals of vascular diseases, 2018 - jstage.jst.go.jp
There is a growing body of evidence that cumulative hyperglycemic exposure plays a central
role in the development and progression of atherosclerotic cardiovascular disease in …
role in the development and progression of atherosclerotic cardiovascular disease in …
Advanced glycation end products: a Nephrologist's perspective
DSC Raj, D Choudhury, TC Welbourne… - American journal of kidney …, 2000 - Elsevier
Advanced glycation end products (AGEs) are a heterogeneous group of molecules that
accumulate in plasma and tissues with advancing age, diabetes, and renal failure. There is …
accumulate in plasma and tissues with advancing age, diabetes, and renal failure. There is …
[HTML][HTML] Toxicity of advanced glycation end products
A Kuzan - Biomedical Reports, 2021 - spandidos-publications.com
Advanced glycation end‑products (AGEs) are proteins or lipids glycated nonenzymatically
by glucose, or other reducing sugars and their derivatives, such as glyceraldehyde …
by glucose, or other reducing sugars and their derivatives, such as glyceraldehyde …
[引用][C] Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
The nonenzymatic glycation of proteins by aldehyde or keto-groups of reducing sugars, in a
process known as the Maillard reaction, eventually leads to the formation of advanced …
process known as the Maillard reaction, eventually leads to the formation of advanced …
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
S Yamagishi - Experimental gerontology, 2011 - Elsevier
A non-enzymatic reaction between ketones or aldehydes and the amino groups of proteins,
lipids and nucleic acids contributes to the aging of macromolecules and to the development …
lipids and nucleic acids contributes to the aging of macromolecules and to the development …
Glycoxidation: the menace of diabetes and aging.
H Vlassara, MR Palace - The Mount Sinai journal of medicine, New …, 2003 - europepmc.org
Advanced glycation end products (AGE) form via the Maillard reaction in vivo and are also
consumed from exogenous sources such as diet and smoking. They alter the structure and …
consumed from exogenous sources such as diet and smoking. They alter the structure and …
Advanced glycation endproducts: what is their relevance to diabetic complications?
N Ahmed, PJ Thornalley - Diabetes, Obesity and Metabolism, 2007 - Wiley Online Library
Glycation is a major cause of spontaneous damage to proteins in physiological systems.
This is exacerbated in diabetes as a consequence of the increase in glucose and other …
This is exacerbated in diabetes as a consequence of the increase in glucose and other …